NCT04789213

Brief Summary

This study aims to compare the short and long term outcomes of living donor and deceased donor liver retransplantation. Bearing that in mind, the investigators will retrospectively analyze the files of patients whom underwent a liver retransplantation in Memorial Bahcelievler Hospital Organ Transplantation Center.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Mar 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 5, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 9, 2021

Completed
1 day until next milestone

Study Start

First participant enrolled

March 10, 2021

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 15, 2021

Completed
16 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2021

Completed
Last Updated

December 6, 2021

Status Verified

December 1, 2021

Enrollment Period

1 month

First QC Date

March 5, 2021

Last Update Submit

December 2, 2021

Conditions

Liver Transplant; ComplicationsLiver Transplant RejectionLiver Transplant FailureLiver DiseasesLiver CirrhosisLiver FailureOrgan Transplant Failure or Rejection

Outcome Measures

Primary Outcomes (1)

  • Survival ratio

    Overall graft and patient survival ratio

    1 minutes

Secondary Outcomes (3)

  • Morbidity

    10 minutes

  • Peri-operative informations

    15 minutes

  • Blood Test Results

    20 minutes

Study Arms (2)

Patients with Living Donor Liver Transplantation

Other: Liver Transplantation

Patients with Deceased Donor Liver Transplantation

Other: Liver Transplantation

Interventions

Liver TransplantationOTHER

Liver Transplantation

Patients with Deceased Donor Liver TransplantationPatients with Living Donor Liver Transplantation

Eligibility Criteria

Age0 Months+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with liver failure who underwent a second liver transplantation (i.e. re-transplantation)

You may qualify if:

  • Having a liver retransplantation

You may not qualify if:

  • N/A

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Memorial Bahçelievler Hospital

Istanbul, 34700, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Liver DiseasesLiver CirrhosisLiver FailureRejection, Psychology

Interventions

Liver Transplantation

Condition Hierarchy (Ancestors)

Digestive System DiseasesFibrosisPathologic ProcessesPathological Conditions, Signs and SymptomsHepatic InsufficiencySocial BehaviorBehavior

Intervention Hierarchy (Ancestors)

Tissue TransplantationCell- and Tissue-Based TherapyBiological TherapyTherapeuticsDigestive System Surgical ProceduresSurgical Procedures, OperativeOrgan TransplantationTransplantation

Study Officials

  • Kamil Yalçın Polat, Prof

    Memorial Bahçelievler Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof.Dr.

Study Record Dates

First Submitted

March 5, 2021

First Posted

March 9, 2021

Study Start

March 10, 2021

Primary Completion

April 15, 2021

Study Completion

May 1, 2021

Last Updated

December 6, 2021

Record last verified: 2021-12

Data Sharing

IPD Sharing
Will not share

Locations

TU(1)